Acrivon Therapeutics, Inc. Common Stock — Institutional Ownership
Which tracked institutions hold ACRV, and how they changed the position last quarter. Latest holdings as of Jun 30, 2026. Source: SEC 13-F filings.
13
Funds holding
$854231
Total value held
Buying
8 added/new · 4 reduced
| # | Institution | Value | Shares | Δ Shares | Change (QoQ) |
|---|---|---|---|---|---|
| 1 | Blackrock, Inc. | $425620 | 239112 | +30173 | +14.44% |
| 2 | Northern Trust Corp | $119620 | 67202 | +18300 | +37.42% |
| 3 | State Street Corp | $119518 | 67145 | — | Held |
| 4 | Ubs Group Ag | $78053 | 43850 | +43850 | NEW BUY |
| 5 | Bank Of America Corp /De/ | $29204 | 16407 | -106 | -0.64% |
| 6 | Goldman Sachs Group Inc | $26558 | 14920 | +178 | +1.21% |
| 7 | Marex Group Ltd | $17800 | 10000 | -10000 | -50.00% |
| 8 | Federated Hermes, Inc. | $14105 | 7924 | +7924 | NEW BUY |
| 9 | Barclays Plc | $13090 | 7354 | +1414 | +23.80% |
| 10 | Morgan Stanley | $9315 | 5233 | -31438 | -85.73% |
| 11 | Jpmorgan Chase & Co | $1337 | 751 | +113 | +17.71% |
| 12 | Citigroup Inc | $11 | 6 | -14586 | -99.96% |
| 13 | Royal Bank Of Canada | $0 | 30 | +5 | +20.00% |
Aggregated across tracked institutional filers. Reported quarterly on SEC Form 13-F and may lag. For research only — not investment advice.